AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

BYSI · NASDAQ · Biotechnology

BeyondSpring (BYSI)

Develops Plinabulin for cancer indications with standard-of-care agents.

$0.6209

At close+0.02 (+3.04%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions21 holders · as of Mar 31, 2026	14.55%	5.98M shares
Insiders4 holders · as of Jul 6, 2026	0.19%	78.1K shares
Strategic holders2 holders · as of Oct 20, 2025	6.74%	2.77M shares
Otherremainder	78.52%	32.28M shares

41.12M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Decheng Capital LLCInstitution	9.24%	3.80M	13Fas of Mar 31, 2026
Decheng Capital China Life Sciences USD Fund III, L.P.Strategic10 percent owner	3.69%	1.52M	Form 4filed Oct 20, 2025 ↗
Shenzhen Sangel Capital Management Limited CompanyStrategic	3.05%	1.25M	13G/Afiled Feb 14, 2022 ↗
BlackRock, Inc.Institution	1.58%	649,462	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	1.48%	607,934	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.91%	375,371	13Fas of Mar 31, 2026
State Street CorpInstitution	0.56%	231,120	13Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution	0.44%	179,925	13Fas of Mar 31, 2026
Northern Trust CorpInstitution	0.17%	69,268	13Fas of Mar 31, 2026
Jiangwen MajetiInsiderdirector	0.12%	50,914	Form 4filed Dec 31, 2024 ↗
Tanaka Capital Management IncInstitution	0.06%	26,296	13Fas of Mar 31, 2026
Patrick FabbioInsiderdirector	0.06%	24,592	Form 4filed Dec 31, 2024 ↗
Meridian Wealth Management, LLCInstitution	0.04%	15,000	13Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution	0.03%	11,100	13Fas of Mar 31, 2026
Vanguard Global Advisers, LLCInstitution	0.01%	4,802	13Fas of Mar 31, 2026
Morgan StanleyInstitution	0.01%	4,570	13Fas of Mar 31, 2026
National Bank of Canada /FI/Institution	0.01%	2,875	13Fas of Mar 31, 2026
Min QiuInsiderofficer: Chief Executive Officer	0.01%	2,498	Form 4filed Jul 6, 2026 ↗
Trifecta Capital Advisors, LLCInstitution	0.00%	1,500	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.00%	1,170	13Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution	0.00%	1,011	13Fas of Mar 31, 2026
Simplex Trading, LLCInstitution	0.00%	864	13Fas of Mar 31, 2026
JPMorgan Chase & CoInstitution	0.00%	297	13Fas of Mar 31, 2026
Yingjuan June LuInsiderofficer: Chief Scientific Officer	0.00%	100	Form 4filed Dec 31, 2024 ↗
Sbi Securities Co., Ltd.Institution	0.00%	87	13Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

21 holders · 5.98M shares · 5 new positions · 10 increased · 3 reduced · 8 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Decheng Capital LLC	3.80M	9.24%	0	May 13, 2026
BlackRock, Inc.	649.5K	1.58%	−21.0K	May 13, 2026
Vanguard Capital Management LLC	607.9K	1.48%	+607.9Knew	May 15, 2026
Geode Capital Management, LLC	375.4K	0.91%	+6.7K	May 15, 2026
State Street Corp	231.1K	0.56%	0	May 15, 2026
Vanguard Fiduciary Trust Co	179.9K	0.44%	+179.9Knew	May 8, 2026
Northern Trust Corp	69.3K	0.17%	0	May 14, 2026
Tanaka Capital Management Inc	26.3K	0.06%	0	May 18, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Oct 17, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	45,513	$1.76	1,518,893
Oct 16, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	85,798	$1.72	1,564,406
Oct 15, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	17,960	$1.65	1,650,204
Oct 14, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	28,495	$1.65	1,668,164
Oct 13, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	107,361	$1.70	1,696,659
Oct 10, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	2,390	$1.77	1,804,020
Oct 9, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	3,979	$1.81	1,806,410
Oct 8, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	7,507	$1.77	1,810,389
Oct 7, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	2,100	$1.79	1,817,896
Oct 6, 2025	Decheng Capital China Life Sciences USD Fund III, L.P.10 percent owner	Sale	17,500	$1.78	1,819,996

CongressHouse and Senate disclosures

Not reported.